9:00am ET
Health and Healthcare
Big Pharma Short Sellers Hike Their Bets
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Companies
/Healthcare
Lilly(Eli) & Company
$1,189.41
▼ $44.25 (−3.59%) today
Markets closed · 7:49pm ET
LLY Coverage
Page 208:50am ET
Health and Healthcare
Big Pharma Scares Off Short Sellers
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
9:59am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
10:25am ET
Health and Healthcare
Eli Lilly Just Couldn’t Get It Together in Q3
Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.
Chris Lange 6:45am ET
Health and Healthcare
How Biotech and Big Pharma Have Upside Heading Into Earnings
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
12:10pm ET
Health and Healthcare
Plaque Psoriasis Suffers May Have Better Option After Eli Lilly Study
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
Chris Lange 10:45am ET
Health and Healthcare
Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
12:00pm ET
Health and Healthcare
Surprising Reaction to Lung Cancer Study Results
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer.
Chris Lange 2:00pm ET
Health and Healthcare
Is NextCure the Next Big Cancer Biotech Every Investor Missed?
NextCure appears to be one of those companies that has flown under the radar of the investing community since its initial public offering in 2019.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
11:00am ET
Health and Healthcare
Huge Plaque Psoriasis Breakthrough at Eli Lilly
Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.
Chris Lange